Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary

Orchestra Biomed Holdings

11/08/2026 24:22

Orchestra Biomed Holdings Inc OBIO.OQ reported a quarterly adjusted loss of 38 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -50 cents.  The mean expectation of seven analysts for the quarter was for a loss of 39 cents per share. Wall Street expected results to range from -49 cents to -28 cents per share.
Revenue fell 89.5% to $88.00 thousand from a year ago; analysts expected $121.40 thousand. 
Orchestra Biomed Holdings Inc's reported EPS for the quarter was a loss of 38 cents​.
The company reported a quarterly loss of $24.08 million.
Orchestra Biomed Holdings Inc shares had fallen by 1.7% this quarter and gained 2.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 11.2% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Orchestra Biomed Holdings Inc is $10.00, about 55.4% above its last closing price of $4.46
This summary was machine generated from LSEG data August 10 at 11:22 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.39
-0.38
Beat
Mar. 31 2026 
-0.43
-0.33
Beat
Dec. 31 2025 
-0.38
-0.13
Beat
Sep. 30 2025 
-0.43
-0.40
Beat